Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ribera

Showing results (451-460 of 473) with videos related to

Pageof 48
Sort By:
Blood|December 15, 2010
Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimensPau Montesinos, Chelo Rayón, Edo Vellenga, et al.
Blood|March 25, 2009
Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantationJosé L Díez-Martín, Pascual Balsalobre, Alessandro Re, et al.
Journal of Hematotherapy & Stem Cell Research|August 31, 2002
Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34(+) cell yieldsJavier De la Rubia, Cristina Arbona, Consuelo Del Cañizo, et al.
Leukemia|February 7, 2012
Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemiaA Vilas-Zornoza, X Agirre, G Abizanda, et al.
Blood Cancer Journal|October 3, 2015
The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemiaM Díaz-Beyá, S Brunet, J Nomdedéu, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|August 30, 2007
[Recommendations for diagnosis and treatment of aged hypertensives]J Macías, N R Robles, J Herrera, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patientsJ Bladé, J F San Miguel, M Fontanillas, et al.
British Journal of Haematology|July 27, 2001
Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: a study of the PETHEMA groupM González, E Barragán, P Bolufer, et al.
Arquivos Brasileiros De Cardiologia|January 15, 2026
Comparison between Five Risk Scores in Patients with Acute Coronary Syndromes Undergoing Surgical Revascularization during the Index HospitalizationJosé C Nicolau, Roberto R C V Giraldez, Fabio B Jatene, et al.
The Australasian Journal of Dermatology|July 12, 2023
Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish populationA Sahuquillo-Torralba, M Hospital-Gil, E Vilarrasa-Rull, et al.
Pageof 48

Showing results (451-460 of 473) with videos related to

Sort By:
Pageof 48
Blood|December 15, 2010
Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimensPau Montesinos, Chelo Rayón, Edo Vellenga, et al.
Blood|March 25, 2009
Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantationJosé L Díez-Martín, Pascual Balsalobre, Alessandro Re, et al.
Journal of Hematotherapy & Stem Cell Research|August 31, 2002
Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34(+) cell yieldsJavier De la Rubia, Cristina Arbona, Consuelo Del Cañizo, et al.
Leukemia|February 7, 2012
Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemiaA Vilas-Zornoza, X Agirre, G Abizanda, et al.
Blood Cancer Journal|October 3, 2015
The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemiaM Díaz-Beyá, S Brunet, J Nomdedéu, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|August 30, 2007
[Recommendations for diagnosis and treatment of aged hypertensives]J Macías, N R Robles, J Herrera, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patientsJ Bladé, J F San Miguel, M Fontanillas, et al.
British Journal of Haematology|July 27, 2001
Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: a study of the PETHEMA groupM González, E Barragán, P Bolufer, et al.
Arquivos Brasileiros De Cardiologia|January 15, 2026
Comparison between Five Risk Scores in Patients with Acute Coronary Syndromes Undergoing Surgical Revascularization during the Index HospitalizationJosé C Nicolau, Roberto R C V Giraldez, Fabio B Jatene, et al.
The Australasian Journal of Dermatology|July 12, 2023
Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish populationA Sahuquillo-Torralba, M Hospital-Gil, E Vilarrasa-Rull, et al.
Pageof 48